Altamira Therapeutics Announces 2024 Annual Meeting
Company Announcements

Altamira Therapeutics Announces 2024 Annual Meeting

Altamira Therapeutics Ltd. (CYTO) has released an update.

Altamira Therapeutics Ltd. has announced its Annual General Meeting for shareholders to be held on May 16, 2024, in Bermuda, with key agenda items including the election of four director nominees, appointment of auditors, and approval of executive compensation. Additionally, proposals will be voted on concerning the reduction of the share premium account, increasing authorised share capital, and other business matters. The company has made all relevant documentation available for shareholder review on its website and offers electronic voting options.

For further insights into CYTO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAltamira Therapeutics provides update on Nasdaq listing
TipRanks Auto-Generated NewsdeskAltamira Therapeutics Faces Nasdaq Delisting
TheFlyAltamira obtains extended ISO 13485 quality management system certification
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App